Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 7/2002

01-11-2002

Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma

Authors: Kewal Asosingh, Eline Menu, Els Van Valckenborgh, Isabelle Vande Broek, Ivan Van Riet, Ben Van Camp, Karin Vanderkerken

Published in: Clinical & Experimental Metastasis | Issue 7/2002

Login to get access
Metadata
Title
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma
Authors
Kewal Asosingh
Eline Menu
Els Van Valckenborgh
Isabelle Vande Broek
Ivan Van Riet
Ben Van Camp
Karin Vanderkerken
Publication date
01-11-2002
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 7/2002
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1020987830132

Other articles of this Issue 7/2002

Clinical & Experimental Metastasis 7/2002 Go to the issue

OriginalPaper

Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion

OriginalPaper

Quantification of human Alu sequences by real-time PCR – an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants

OriginalPaper

Deregulated activation of matriptase in breast cancer cells

OriginalPaper

Redistribution of fibroblasts and macrophages as micrometastases develop into established liver metastases

OriginalPaper

A murine model of bone marrow micrometastasis in breast cancer

OriginalPaper

Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits